Oliger Christy J.
CIK: 0001822092
Director
Primary company: REATA PHARMACEUTICALS INC (RETA)
Oliger Christy J. is a corporate insider at REATA PHARMACEUTICALS INC (RETA) filing SEC Form 4 transactions. 38 transactions across 8 companies. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
Nuvalent, Inc. NUVL | Disposition | 6,119 | $75.53 | $462K | 0 | 7/15/2026 Filed: 7/15/2026 | Filing → |
Nuvalent, Inc. NUVL | Disposition | 6,091 | - | - | 0 | 7/15/2026 Filed: 7/15/2026 | Filing → |
Nuvalent, Inc. NUVL | U | 1,324 | $124.00 | $164K | 0 | 7/15/2026 Filed: 7/15/2026 | Filing → |
Nuvalent, Inc. NUVL | Award | 3,444 | - | - | 7,415 | 6/16/2026 Filed: 6/16/2026 | Filing → |
| Award | 17,084 | $34.35 | $587K | 17,084 | 5/21/2026 Filed: 5/21/2026 | Filing → | |
| Award | 44,500 | $7.61 | $339K | 44,500 | 4/1/2026 Filed: 4/1/2026 | Filing → | |
LAVA Therapeutics NV LVTX | Disposition | 33,390 | - | - | 0 | 11/13/2025 Filed: 11/17/2025 | Filing → |
Nuvalent, Inc. NUVL | Award | 6,119 | - | - | 6,119 | 6/18/2025 Filed: 6/20/2025 | Filing → |
Nuvalent, Inc. NUVL | Award | 3,971 | - | - | 3,971 | 6/18/2025 Filed: 6/20/2025 | Filing → |
| Award | 4,600 | - | - | 4,600 | 5/28/2025 Filed: 5/29/2025 | Filing → | |
| Award | 14,000 | - | - | 14,000 | 5/14/2025 Filed: 5/16/2025 | Filing → | |
| Award | 32,000 | - | - | 32,000 | 4/1/2025 Filed: 4/3/2025 | Filing → | |
LAVA Therapeutics NV LVTX | Award | 33,390 | $0.93 | $31K | 33,390 | 2/13/2025 Filed: 2/18/2025 | Filing → |
| Award | 25,000 | - | - | 25,000 | 6/7/2024 Filed: 6/11/2024 | Filing → | |
| Award | 69,000 | - | - | 69,000 | 5/29/2024 Filed: 5/30/2024 | Filing → | |
| Award | 32,000 | - | - | 32,000 | 4/1/2024 Filed: 4/3/2024 | Filing → | |
RayzeBio, Inc. RYZB | Disposition | 114,579 | - | - | 0 | 2/26/2024 Filed: 2/27/2024 | Filing → |
REATA PHARMACEUTICALS INC RETA | Disposition | 2,137 | - | - | 0 | 9/26/2023 Filed: 9/26/2023 | Filing → |
REATA PHARMACEUTICALS INC RETA | Disposition | 5,620 | - | - | 0 | 9/26/2023 Filed: 9/26/2023 | Filing → |
REATA PHARMACEUTICALS INC RETA | Disposition | 180 | - | - | 0 | 9/26/2023 Filed: 9/26/2023 | Filing → |
Nuvalent, Inc.
NUVL
Type
Disposition
Shares
6,119
Price
$75.53
Value
$462K
Nuvalent, Inc.
NUVL
Type
Disposition
Shares
6,091
Price
-
Value
-
Nuvalent, Inc.
NUVL
Type
U
Shares
1,324
Price
$124.00
Value
$164K
Nuvalent, Inc.
NUVL
Type
Award
Shares
3,444
Price
-
Value
-
Type
Award
Shares
17,084
Price
$34.35
Value
$587K
Type
Award
Shares
44,500
Price
$7.61
Value
$339K
LAVA Therapeutics NV
LVTX
Type
Disposition
Shares
33,390
Price
-
Value
-
Nuvalent, Inc.
NUVL
Type
Award
Shares
6,119
Price
-
Value
-
Nuvalent, Inc.
NUVL
Type
Award
Shares
3,971
Price
-
Value
-
Type
Award
Shares
4,600
Price
-
Value
-
Type
Award
Shares
14,000
Price
-
Value
-
Type
Award
Shares
32,000
Price
-
Value
-
LAVA Therapeutics NV
LVTX
Type
Award
Shares
33,390
Price
$0.93
Value
$31K
Type
Award
Shares
25,000
Price
-
Value
-
Type
Award
Shares
69,000
Price
-
Value
-
Type
Award
Shares
32,000
Price
-
Value
-
RayzeBio, Inc.
RYZB
Type
Disposition
Shares
114,579
Price
-
Value
-
REATA PHARMACEUTICALS INC
RETA
Type
Disposition
Shares
2,137
Price
-
Value
-
REATA PHARMACEUTICALS INC
RETA
Type
Disposition
Shares
5,620
Price
-
Value
-
REATA PHARMACEUTICALS INC
RETA
Type
Disposition
Shares
180
Price
-
Value
-
AI Agent
Try asking...